Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD. Maltais F, Vogelmeier CF, Kerwin EM, Bjermer LH, et al. Respir Med 2022;200:106918.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maltais F, Vogelmeier CF, Kerwin EM, Bjermer LH, et al. Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD. Respir Med 2022;200:106918.
PMID: 35803172